1. Most primary brain tumors are rare;
2. Chordoma and meningioma are potentially devastating cancers with no known effective medical therapies; and
3. Combining immune-based approach with conventional treatment strategies may be more effective.


Session date: 
Thursday, October 12, 2017 - 3:00pm to 4:00pm
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Deric Park MD